Guiting, Jovelyn .
HRN: 23-81-31 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2023
CLINDAMYCIN 300MG (CAP)
10/23/2023
10/29/2023
ORAL
300mg
Q6
Perineal Abscess On Episiotomy Site
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes